Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1998;29:2080-2086

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Koning, I.
Right arrow Articles by Koudstaal, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Koning, I.
Right arrow Articles by Koudstaal, P. J.

(Stroke. 1998;29:2080-2086.)
© 1998 American Heart Association, Inc.


Original Contributions

The CAMCOG: A Useful Screening Instrument for Dementia in Stroke Patients

Inge de Koning, MA; Fop van Kooten, MD; Diederik W.J. Dippel, MD, PhD; Frans van Harskamp, MD; Diederick E. Grobbee, MD, PhD; Cornelis Kluft, PhD; Peter J. Koudstaal, MD, PhD

From the Department of Neurology, University Hospital Rotterdam-Dijkzigt, Rotterdam (I. de K., F. van K., D.W.J.D., F. van H., P.J.K.); Julius Center for Patient Oriented Research, Utrecht University, Utrecht (D.E.G.); and TNO-PG, Gaubius Laboratory, Leiden (C.K.), the Netherlands.

Correspondence to I. de Koning, Department of Neurology, University Hospital Rotterdam-Dijkzigt, dr Molewaterplein 40, 3015 GD Rotterdam, Netherlands. E-mail dekoning{at}neur.azr.nl

Background and Purpose—Most mental screening tests focus on the detection of cognitive deficits compatible with Alzheimer's disease. Stroke patients who develop a dementia syndrome, however, constitute a more heterogeneous group with both cortical and subcortical disturbances. We assessed the diagnostic accuracy of the CAMCOG (the cognitive and self-contained part of the Cambridge Examination for Mental Disorders of the Elderly) and the Mini-Mental State Examination (MMSE) for dementia in patients with a recent stroke.

Methods—In patients aged 55 and older who were admitted in the Rotterdam Stroke Databank, cognitive functioning was assessed between 3 and 9 months after the most recent stroke. The "gold standard" diagnosis of dementia was compatible with the criteria of the Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. The CAMCOG and MMSE scores were obtained independent of the diagnostic procedure.

Results—Of 300 consecutive patients, 71 (23.7%) were demented. Sixteen severely demented patients could not be tested and were excluded. The CAMCOG and MMSE scores were significantly related to dementia (both P<0.0001) in a logistic regression model. Receiver operating characteristic analysis showed that the CAMCOG was a more accurate screening instrument (area under the curve for CAMCOG, 0.95; for MMSE, 0.90). Two other clinical variables independently improved the diagnostic accuracy of the MMSE and CAMCOG: patients with a left hemispheric lesion had a lower (odds ratio, 0.3; 95% confidence interval, 0.1 to 0.7), and patients with hemorrhagic stroke had a greater chance of being demented (odds ratio, 3; 95% confidence interval, 1 to 10). The effect of left hemispheric lesion as an independent diagnostic factor could not be explained by selection or its association with aphasia alone.

Conclusions—The CAMCOG is a feasible instrument for use in patients with a recent transient ischemic attack or stroke. It is a more accurate screening tool for dementia than the MMSE, especially when type and site of stroke are taken into account.


Key Words: cognitive screening • dementia • neuropsychological tests • stroke




This article has been cited by other articles:


Home page
NeurologyHome page
G. C. Newman, H. Bang, S. I. Hussain, and J. F. Toole
Association of diabetes, homocysteine, and HDL with cognition and disability after stroke
Neurology, November 27, 2007; 69(22): 2054 - 2062.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C.A.R. Martins, A. Oulhaj, C. A. de Jager, and J. H. Williams
APOE alleles predict the rate of cognitive decline in Alzheimer disease: A nonlinear model
Neurology, December 27, 2005; 65(12): 1888 - 1893.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
E. Rowan, C.M. Morris, S. Stephens, C. Ballard, H. Dickinson, H. Rao, B.K. Saxby, A.T. McLaren, R.N. Kalaria, and R.A. Kenny
Impact of Hypertension and Apolipoprotein E4 on Poststroke Cognition in Subjects >75 Years of Age
Stroke, September 1, 2005; 36(9): 1864 - 1868.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
G. M.S. Nys, M. J.E. van Zandvoort, P. L.M. de Kort, H. B. van der Worp, B. P.W. Jansen, A. Algra, E. H.F. de Haan, and L. J. Kappelle
The prognostic value of domain-specific cognitive abilities in acute first-ever stroke
Neurology, March 8, 2005; 64(5): 821 - 827.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
I de Koning, F van Kooten, P J Koudstaal, and D W J Dippel
Diagnostic value of the Rotterdam-CAMCOG in post-stroke dementia
J. Neurol. Neurosurg. Psychiatry, February 1, 2005; 76(2): 263 - 265.
[Abstract] [Full Text] [PDF]


Home page
Neurorehabil Neural RepairHome page
M. Hoffmann
Higher Cortical Function Deficits After Stroke: An Analysis of 1,000 Patients from a Dedicated Cognitive Stroke Registry
Neurorehabil Neural Repair, March 1, 2001; 15(2): 113 - 127.
[Abstract] [PDF]


Home page
StrokeHome page
I. de Koning, D. W.J. Dippel, F. van Kooten, and P. J. Koudstaal
A Short Screening Instrument for Poststroke Dementia : The R-CAMCOG
Stroke, July 1, 2000; 31(7): 1502 - 1508.
[Abstract] [Full Text] [PDF]